Arcturus Bioscience Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Arcturus Bioscience General Information

Description

Developer of technology platform for genetic analysis of biopsy samples to discover cell-specific gene signatures. The company develops laser capture microdissection (LCM) instruments and reagents for the analysis of microscopic tissue samples, with systems installed in cancer centers and other research and clinical laboratories worldwide.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
  • 400 Logue Avenue
  • Mountain View, CA 94043
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcturus Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Apr-2006 000.00 Completed Generating Revenue
2. Bridge 28-Nov-2005 00.000 000.00 Completed Generating Revenue
1. Later Stage VC (Series G) 01-Apr-2004 $16.4M $16.4M Completed Generating Revenue
To view Arcturus Bioscience’s complete valuation and funding history, request access »

Arcturus Bioscience Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ABS Capital Partners Growth/Expansion Minority 000 0000 000000 0
DynaFund Ventures Venture Capital Minority 000 0000 000000 0
Summit Partners PE/Buyout Minority 000 0000 000000 0
To view Arcturus Bioscience’s complete investors history, request access »